Therapeutic Advances in Medical Oncology
eISSN:
17588359 | ISSN:
17588359 | Current volume: 15 | Current issue: 1
Frequency: Yearly
Journal Highlights
- Gold open access journal – all articles are made freely available online immediately upon publication
- Rigorous peer review
- Listed in PubMed and indexed in Web of Science, Science Citation Index Expanded (SCIE) and Scopus
- Internationally renown, expert Editorial Board and panel of Associate Editors
- A leading gold open access journal in oncology
- Over 500,000 full-text article views annually
Therapeutic Advances in Medical Oncology (TAM) is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies in the medical treatment of cancer. Please see the Aims and Scope tab for further information.
This journal is a member of the Committee on Publication Ethics (COPE).
Diversity, Equity and Inclusion Statement
Therapeutic Advances in Medical Oncology (TAM) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the oncology community.
Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.
We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.
We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.
Submission information
Submit your manuscript today at http://mc.manuscriptcentral.com/tao.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence.
The APC for this journal is currently 2800 USD. The article processing charge for Plain Language Summary is 4500 USD.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
This journal flipped to open access on September 1, 2016.
Contact
Please direct any queries to oncology@sagepub.co.uk.
Therapeutic Advances in Medical Oncology delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of cancer. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in medical oncology, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.
Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). Therapeutic Advances in Medical Oncology conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees; and Online First publication is usually within 3 weeks of Acceptance.
Executive Editor
| Georgia Patey | SAGE Publications Ltd, London, UK |
Managing Editor
| Joshua Gazmin | SAGE Publishing, London, UK |
Associate Editors
| Rodabe Amaria, MD | Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA |
| Aditya Bardia, MD | Breast Oncology Program and Medical Oncology Division, UCLA Health Jonsson Comprehensive Cancer Center, LA, USA |
| Giuseppe Curigliano, MD, PhD | Department of Oncology and Hemato-Oncology, University of Milano and European Institute of Oncology, IRCCS, Milano, Italy |
| Ian D. Davis | Monash University, Australia |
| Karim Fizazi, MD, PhD | Institut Gustave Roussy, University of Paris Saclay, France |
| Sharlene Gill, MD, MPH, MBA, FRCPC | Medical Oncology, BC Cancer - Vancouver, University of British Columbia, Canada |
| Robert Haddad, MD | Division of Head and Neck Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA |
| Nadia Harbeck, MD, PhD | University of Munich, Germany |
| Sara Hurvitz, MD, FACP | David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, UCLA, CA, USA |
| Jonathan Ledermann, MBBS, MRCP, MD, FRCP | UCL Cancer Institute, University College London, UK |
| Natasha Leighl, MD | Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada |
| Javier Martin-Broto, MD, PhD, ASCO, ESMO | Fundacion Jimenez Diaz University Hospital, Madrid, Spain |
| Keunchil Park, MD, PhD | Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, TX, USA |
| Matthias Preusser, MD, PhD, EORTC, EANO, ESMO | Division of Oncology, Department of Medicine I, Medical University of Vienna, Austria |
| Liang Qiao, PhD, EASL, ASSCR, CRA | The University of Sydney, Westmead, Australia |
| Rachel Riechelmann, MD, PhD, ESMO, SLAGO, LACOG | Clinical Oncology Department, AC Camargo Cancer Center, Sao Paulo, Brazil |
| Rachna Shroff, MD, MS, FASCO | University of Arizona Cancer Center, University of Arizona College of Medicine – Tucson, AZ, USA |
| Ross Soo, MBBS, FRACP, FAMS, ASCO, IASLC, SSO | Department of Haematology-Oncology, National University Cancer Institute, Singapore |
| Srikala Sridhar, MD, CCTG | Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada |
| David Tan, PhD | American University of the Middle East, Kuwait and Macquarie University, Australia |
| Hanneke van Laarhoven, MD, ESMO | Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, the Netherlands |
| Arndt Vogel, MD, ESMO, ASCO, EASL | Toronto General Hospital and University of Toronto, Canada |
Breast cancer editorial board members
| Carlos Barrios, MD | Latin American Cooperative Oncology Group (LACOG), Oncoclínicas, Porto Alegre, Brazil |
| Evandro De Azambuja, MD, PhD | Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Belgium |
| Alessandra Gennari, MD, PhD | Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy |
| Kevin Kalinsky, MD, MS | Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, USA |
| Sung-Bae Kim, MD, PhD | Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea |
| Bora Lim, MD | Division of Cancer Medicine, The UT MD Anderson Cancer Center, TX, USA |
| Miguel Martín, MD, PhD | Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain |
| Nicholas McAndrew, MD, MSCE | Division of Hematology/Oncology, UCLA David Geffen School of Medicine, CA, USA |
| Yeon Hee Park, MD, PhD | Sungkyunkwan University School of Medicine, Seoul, Korea |
| Sagar Sardesai, MD, MPH | Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, OH, USA |
| Cristina Saura, MD, PhD | Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Spain |
| Peter Schmid, FRCP, MD, PhD | Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK |
| Priyanka Sharma, MD | Division of Medical Oncology, University of Kansas Medical Center and Drug Discovery, Delivery and Experimental Therapeutics program, University of Kansas Cancer Center, USA |
| Rebecca Shatsky, MD | Comprehensive Breast Health Center, University of California San Diego, USA |
| Laura Spring, MD | Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA |
| Paolo Tarantino, MD | Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA |
| Sara Tolaney, MD, MPH | Division of Breast Oncology, Dana-Farber Cancer Institute, MA, USA & Harvard Medical School, MA, USA |
| Neelima Vidula, MD | Massachusetts General Hospital Boston, USA |
| Nikhil Wagle, MD | Genentech, South San Francisco, California, USA |
| Seth Wander, MD, PhD | Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA |
| Yoon-Sim Yap, MBBS, FRACP, PhD | National Cancer Centre Singapore, Duke-National University Singapore (Duke-NUS), Singapore |
Central Nervous System Tumors
| Priscilla Brastianos, MD | Central Nervous System Metastasis Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA |
| Enrico Franceschi, MD | Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy |
| Patrick Roth, MD | University Hospital Zurich, Department of Neurology and Brain Tumor Center Zurich, Switzerland |
Genitourinary Cancer Editorial Board members
| Giulia Baciarello, MD | Department of Medical Oncology, S. Camillo-Forlanini Hospitals, Rome, Italy |
| Elena Castro, MD, PhD | Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain |
| Kim N Chi, MD, FRCPC | University of British Columbia, Vancouver, BC, Canada |
| Toni K Choueiri, MD | Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA |
| Maria De Santis, MD | Charité University Hospital, Germany |
| Tim Eisen, PhD | Cambridge University, Cambridge, UK |
| Felix Feng, MD | Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA |
| Matt Galsky | Tisch Cancer Institute, USA |
| Pooja Ghatalia, MD | Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA |
| Petros Grivas, MD PhD | Department of Medicine, Division of Oncology, University of Washington, Fred Hutchinson Cancer Center, Seattle, United States |
| Lisa G. Horvath, MBBS, FRACP, PhD | Department of Medical Oncology, Chris O’Brien Lifehouse, University of Sydney, Sydney, Australia |
| Maha Hussain, MD, FACP, FASCO | Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, USA |
| Lorena Incorvaia, MD, PhD | Department of Biomedicine, Neuroscience and Advanced Diagnostic (BiND), Section of Medical Oncology, University of Palermo, Italy |
| Ravindran Kanesvaran, MD, MRCP, FAMS | Division of Medical Oncology, National Cancer Centre Singapore, Singapore |
| Alicia Morgans, MD, MPH | Harvard Medical School/ Survivorship Program, Dana-Farber Cancer Institute, Boston, MA |
| Kent Mouw, MD, PhD | Dana-Farber Cancer Institute/Brigham & Women’s Hospital/Harvard Medical School, Boston, MA, USA |
| Jones Nauseef, MD, PhD | Convergent Therapeutics, Boston, MA; Weill Cornell Medicine, New York, NY, USA |
| Anna Patrikidou, MD, PhD | Department of Cancer Medicine, Gustave Roussy Institute, University of Paris Saclay, Villejuif, France |
| David Quinn, MBBS (Hons I), PhD, FRACP, FACP | University of Minnesota, USA |
| Marniza Saad, FRCR, MBBCh | Department of Clinical Oncology, Universiti Malaya Medical Centre, Kuala Lumpur, Malaysia |
| Scott Tagawa, MD, MS, FACP, FASCO | Weill Cornell Medicine, New York, NY, USA |
| Ben Tran, MBBS | Peter MacCallum Cancer Centre, Australia |
Gastrointestinal Cancer Editorial Board members
| Thomas Aparicio, MD, PhD | Assistance Publique - Hôpitaux de Paris, Saint-Louis Hospital, Gastroenterology and Digestive Oncology Department, Université de Paris Cité, Paris, France |
| Dirk Arnold, MD | Asklepios Tumorzentrum Hamburg, AK Altona |
| Eishi Baba, MD, PhD | Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, Japan |
| Irit Ben-Aharon, MD, PhD | Fishman Oncology Center, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion, Haifa, Israel |
| Sakti Chakrabarti, MD | Division of Hematology and Medical Oncology at UH Seidman Cancer Center, Case Comprehensive Cancer Center, and Case Western Reserve University, OH, USA |
| Stephen Chan, MBBS, MRCP, FHKCP, FHKAM, FRCP, FRCP | The Chinese University of Hong Kong, Hong Kong |
| Yun Dai, MD | Department of Gastroenterology, Peking University First Hospital, Beijing, China |
| Richard Finn, MD | Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, CA, USA |
| Aysegül Ilhan-Mutlu, MD, PhD | Division of Oncology, Department of Medicine I, Director of Gastroesophageal Tumors Unit, Medical University of Vienna, Austria |
| Yumin Li, PhD | Lanzhou University and Lanzhou University Second Hospital, China |
| Jonathan Loree, MD, MS, FRCPC | Division of Medical Oncology, BC Cancer, Vancouver, Canada |
| Teresa Macarulla, MD, PhD | Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Barcelona, Spain |
| Matthew Ng, PhD | National Cancer Centre Singapore, Singapore |
| Radka Obermannová, MD, PhD | Department of Comprehensive Cancer Care and Faculty of Medicine, Masaryk University, Masaryk Memorial Cancer Institute, Czech Republic |
| Gerald Prager, MD, PhD | Department of Medical Oncology, Medical University of Vienna (MUV) and Comprehensive Cancer Center Vienna, Austria |
| Lorenza Rimassa, MD | Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy |
| Olivier Rosmorduc, MD, PhD | Hepato-Biliary Center, Paul Brousse Hospital, Paris Saclay University, Villejuif, France |
| Debashis Sarker, MBChB, MRCP, PhD | King's College London, UK |
| Thomas Seufferlein, MD, PhD | Department of Internal Medicine 1, University Hospital Ulm, Ulm, Germany |
| Rachna Shroff, MD, MS | University of Arizona Cancer Center, AZ, USA |
| Elizabeth Smyth, MD | Oxford University Hospitals NHS Foundation Trust, Oxford, UK |
| Rebecca K.S. Wong, MB, ChB, MSc, FRCP | Princess Margaret Cancer Center, University Health Network; Department of Radiation Oncology, University of Toronto, Ontario, Canada |
Gynaecological Cancer Editorial Board members
| Susana Banerjee, FRCP, MBBS, MA, PhD | The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK |
| Elena Ioana Braicu, MD, PhD | Department of Gynecology, Charité University Medicine, Campus Virchow, Berlin, Germany |
| Alexandra Leary, MD, PhD | Gustave Roussy Institute, Université Paris Saclay, GINECO group, France |
| Yeh Chen Lee, MBBS, BMedSci, MPhil[H1], FRACP | Prince of Wales and Royal Hospital for Women, NSW, Australia |
| Rowan Miller, MD, PhD | University College London and St Bartholomew's Hospitals, London UK |
| Natalie Ngoi, MD | Department of Hematology-Oncology, National University Cancer Institute, Singapore |
| Angélica Nogueira Rodrigues, MD, PhD | Federal University of Minas Gerais; Latin American Cooperative Oncology Group, Brazil |
| David O'Malley, MD | Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ohio State University College of Medicine (OH, USA) |
| José Pérez-Fidalgo, MD, PhD | Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia (Department of Medicine), Valencia, Spain |
| Bhavana Pothuri, MD, MS | Gynecologic Oncology, NYU Grossman School of Medicine, NYU Langone Health, Laura & Isaac Perlmutter Cancer Center NY, NY, USA |
| Clare Scott, MBBS, PhD | The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Victoria, Australia |
| Ronnie Shapira-Frommer, MD | Ella Lemelbaum Institute for Immuno-oncology & Melanoma and the Onco-gynecology service, Sheba Medical Center, Ramat-Gan, Israel |
| Anna Tinker, MD | Division of Medical Oncology, BC Cancer, Vancouver, Canada |
| Rongyu Zang, MD, PhD | Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China |
Skin Cancer Editorial Board members
| Ana Arance, MD, PhD | Department of Medical Oncology, Hospital Clinic Barcelona, Spain |
| Nikhil Khushalani, MD | H. Lee Moffitt Cancer Center & Research Institute, FL, USA |
| Mark Middleton, MD, PhD | Department of Oncology, University of Oxford, Oxford, UK |
| Yana Najjar, MD | Clinical and Translational Research Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA |
| April Salama, MD | Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Duke University, NC, USA |
Lung Cancer Editorial Board members
| Fiona Blackhall, PhD, FRCP | Department of Medical Oncology, The Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester, Manchester, UK |
| Wilfried Eberhardt, MD | University Duisburg-Essen, Essen, Germany |
| Daichi Fujimoto, MD, PhD | Internal Medicine III, Wakayama Medical University, Wakayama, Japan |
| Justin Gainor, MD | Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA |
| Marina Garassino, MD | Section of Hematology/Oncology, University of Chicago Medicine, Chicago, IL, USA |
| Cesare Gridelli, MD | S.G. Moscati Hospital, Avellino, Italy |
| Lizza Hendriks, MD, PhD | Department of Pulmonary Diseases, Maastricht UMC+, the Netherlands |
| Hidehito Horinouchi, MD, PhD | Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan |
| Ning Li, MD | Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, China |
| Sun Min Lim, MD, PhD | Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea |
| Herbert H. Loong, MBBS, FRCP | Department of Clinical Oncology and Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong |
| Shun Lu, MD, PhD | Department of Medical Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China |
| Laura Mezquita, MD, PhD | Medical Oncology Department, Hospital Clinic of Barcelona; Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS; Department of Medicine, University of Barcelona, Spain |
| Zofia Piotrowska, MD, MHS | Massachusetts General Hospital Cancer Center, Boston, MA, United States |
| Jordi Remon, MD, PhD | Department of Medicine Gustave Roussy, Villejuif, France |
| Christian Rolfo, MD, PhD, MBA,Dr.h.c. | The Center of Thoracic Oncology at the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA |
| Adrian Sacher, MD | Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada |
| Ming-Sound Tsao, MD, FRCPC | Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada |
| Paul Wheatley-Price, BSc, MD MBChB, FRCP | Department of Medicine, Division of Medical Oncology, University of Ottawa, ON, Canada |
| Antoinette Wozniak, MD, FACP, FASCO | UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA |
Neuroendocrine Cancer Editorial Board members
| David Chan, MBBS PhD | University of Sydney, Sydney, Australia |
| Barbara Kiesewetter, MD | Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria |
Head and Neck Cancer Editorial Board members
| Melvin Chua, MBBS, FRCR, PhD, FAMS | Department of Head and Neck and Thoracic Cancers, Division of Radiation Oncology, National Cancer Centre Singapore and Duke-NUS Medical School, Singapore |
| Thorsten Füreder, MD | Department of Medicine I, Division of Oncology, Medical University Vienna, Austria |
| Narayanan Gopalakrishna Iyer, MD, PhD, FRCS | National Cancer Center Singapore |
| Brigette Ma, MBBS(Hon.), FRACP, FHKCP, FHKAM, MD(CUHK) | State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and The Chinese University of Hong Kong, Hong Kong SAR, China |
| Jun Ma, MD, PhD | Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, China |
Sarcoma Editorial Board members
| Albiruni Abdul Razak, MB, MRCPI, CCT | Princess Margaret Cancer Centre, Toronto, Canada |
| Matías Chacón, MD | Instituto Alexander Fleming, Buenos Aires, Argentina |
| Tom Wei Wu Chen, MD, PhD | Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan |
| Alessandro Gronchi, MD | Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy |
| Bruno Vincenzi, MD, PhD | University Campus Bio-Medico, Rome, Italy |
Biostatistical Editors
| Kathleen Boyd, MSc PhD | Health Economics & Health Technology Assessment, School of Health & Wellbeing, University of Glasgow, UK |
| Marc Buyse, ScD, ISCB | International Drug Development Institute (IDDI), and Hasselt University, Belgium |
| Antonio Galvano, PhD | Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy |
| Susan Halabi, PhD | Department of Biostatistics and Bioinformatics, Duke University Medical Center and Duke Cancer Institute, NC, USA |
| Caroline Kelly, MSc, BSc | Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, UK |
| Andrew Martin, PhD | NHMRC Clinical Trials Centre, University of Sydney, Australia |
| Xiwen (Simon) Qin, PhD | University of Hong Kong, Hong Kong |
| Bhupendra Rawal, MSc | Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, MA, USA |
| Qian Shi, PhD | Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA |
| Takeharu Yamanaka | Department of Biostatistics, Yokohama City University School of Medicine, Japan |
| Jinqiu (Jacky) Yuan, MPh, PhD | Clinical Research Centre, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China |
Editorial Reviewer Board
| Hamzeh Albaba, MD | Cross Cancer Institute, Alberta, Canada |
| Sandra Danielle Algaze, MD | USC Norris Comprehensive Cancer Center, CA, USA |
| Prof. Fatemeh Ardeshir-Larijani, MD, MSc | Winship Cancer Institute, Emory School of Medicine, GA, USA |
| Ilaria Attili, MD | European Institute of Oncology, Milan, Italy |
| Ryan C. Augustin, MD | Department of Medicine, University of Pittsburgh, PA, USA |
| Rita Balsano, MD | IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Italy |
| Holly Barker, PhD | The Walter and Eliza Hall Institute of Medical Research (WEHI), Melbourne, Australia |
| Fernando Augusto Batista Campos, MD | Department of Medical Oncology, AC Camargo Cancer Center, São Paulo, SP, Brazil |
| Anthony Bejjani, MD | Division of Hematology/Oncology, VA Greater Los Angeles Health System, Geffen School of Medicine at UCLA, Los Angeles, CA, USA |
| Alice Bernard- Tessier, MD MSc | Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France |
| Christine Bestvina ,MD | The University of Chicago Medicine, Chicago, IL, USA |
| Manali Bhave, MD | Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA |
| Daniel Breadner, MSc MD FRCPC | Division of Medical Oncology, London Regional Cancer Program, London Health Science Center, ON, Canada |
| Ciro Celsa, MD, PhD | University of Palermo, Italy |
| Johan Chan, MBBS, FRACP | National Cancer Centre Singapore, Singapore |
| Siu Ching, MBBS | Chinese University of Hong Kong, Hong Kong |
| Niamh Coleman, MD PhD | Department of Medical Oncology, St. James's Hospital, Trinity College, Dublin, Ireland |
| Ciara Conduit, FRACP MBBS | Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia |
| Rena D. Callahan, MD | Santa Clarita Cancer Care, UCLA Health, US |
| Antonio D’Alessio, MD | Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK |
| Michael John Devlin, MD PhD | Barts Cancer Institute, Queen Mary University of London, London, UK |
| Federico Pio Fabrizio, PhD | University of Enna "Kore", Italy |
| Dechao Feng, MD, PhD | University College London, UK |
| Sarah Elizabeth Fenton, MD PhD | Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA |
| Michael Flynn, MD PhD | Department of Oncology, University College London Hospital, University College London, London, UK |
| Victor Hugo Fonseca de Jesus, MD, MSc | Centro de Pesquisas Oncológicas (CEPON), Brazil |
| Andrea Fung, MD PhD | Department of Oncology, Queen's University, Kingston, ON, Canada |
| Miguel Garcia-Pardo, MD | Hospital Universitario Ramón y Cajal, Madrid, Spain |
| Ana C. Garrido-Castro, MD | Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA |
| Rodrigo Gomes Taboada, MD, MSc | A.C.Camargo Cancer Center, São Paulo, SP, Brazil |
| Martín Igor Gómez-Randulfe Rodríguez, MD | The Christie NHS Foundation Trust, UK |
| Mohamed Gouda, MD, MSc | The University of Texas MD Anderson Cancer Center, Houston, United States |
| Juan Francisco Grau-Béjar, MD MSc | Gynaecologic Cancer Programme, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain |
| Gwo Yaw Ho, BSc (HON), MBChB, FRACP, PhD | Monash University and Monash Health, Austraila |
| Anis Hamid, MBBS | Memorial Sloan Kettering Cancer Center, NY, USA |
| Diana L Hanna, MD | USC Norris Comprehensive Cancer Center, CA, USA |
| Helen Hockings,MB BChir PhD | St Bartholomew's Hospital, London, UK |
| Robert Hsu, MD, MS | University of Southern California, Norris Comprehensive Cancer Center, Keck School of Medicine, CA, USA |
| Hui-Yao Huang, PhD | Department of Clinical Trials Center, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China |
| Laura Huppert, MD | UCSF Helen Diller Family Comprehensive Cancer Center, USA |
| Gino K. In, MD MPH | University of Southern California, Norris Comprehensive Cancer Center, Keck School of Medicine, Division of Oncology, Los Angeles, CA, USA |
| Di (Maria) Jiang, MD MSc FRCPC | Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada |
| Lawrence Kasherman, BMed MMed (ClinEpi) FRACP | Illawarra Cancer Care Centre, Wollongong Hospital and Concord Clinical School, University of Sydney, NSW, Australia |
| Lucy Boyce Kennedy, MD | The Cleveland Clinic Foundation, Cleveland, OH, USA |
| Edmond Kwan, MBBS FRACP PhD | Vancouver Prostate Centre, Department of Urologic Sciences, The University of British Columbia, Vancouver, BC, Canada |
| Ruth Lauren Sacks, MD | Emory University School of Medicine, USA |
| Jieun Lee, MD PhD | Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea |
| Jii Bum Lee, MD | Yonsei Cancer Center, Yonsei University College of Medicine, South Korea |
| Kyung-Hun Lee, MD PhD | Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, Seoul, South Korea |
| Nathalie LeVasseur, MD, FRCPC | Department of Medical Oncology, BC Cancer, Vancouver, Canada |
| Pedro Emanuel Rubini Liedke, MD MSc | Oncoclinicas Porto Alegre and Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil |
| Jasmine Lim, BSc DPhil | Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia |
| Jessica J. Lin, MD | Department of Medicine, Massachusetts General Hospital, Boston, MA, USA |
| Marla Lipsyc-Sharf, MD | Department of Medicine, Dana-Farber Cancer Institute/Mass General Brigham, MA, USA |
| Wen-Yang Liu, MD | Chinese Academy of Medical Sciences and Peking Union Medical College, China |
| Fernando López-Campos, MD PhD MSc | Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain |
| Sara López-Tarruella, MD PhD | Medical Oncology Department, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERONC, Geicam, Universidad Complutense, Madrid, Spain |
| Rebeca Lozano, MD | Medical Oncology Department, Complejo Asistencial Universitario Salamanca, Salamanca, Spain |
| Lucy Ma, MD | Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada |
| Florit Marcuse, MD PhD | Department of Respiratory Medicine, Maastricht University Medical Centre, GROW School for Oncology and Reproduction, Maastricht, Netherlands |
| Antonio Marra, MD MSc | Early Drug Development for Innovative Therapies, European Institute of Oncology IRCSS, Milan, Italy |
| Kristen A. Marrone, MD | Johns Hopkins University School of Medicine, USA |
| Corinne Maurice-Dror, MD | BC Cancer, Vancouver, BC, Canada |
| Arielle J Medford, MD | Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA |
| Alessandra Merlini, MD, PhD | University of Turin, Orbassano (TO), Italy |
| Kenji Morimoto, MD, PhD | Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan |
| Fabiana Napolitano, MD, PhD | Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX |
| Vishal Navani, MA (Oxon) MBBS (Lon) MRCP FRACP | Tom Baker Cancer Centre, Calgary, Canada & University of Calgary, Calgary, Canada |
| Romario Nguyen, PhD | Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital, NSW, Australia |
| Angelica Petrillo, MD | Medical Oncology Unit, Ospedale del Mare, Napoli, Italy |
| Quincy SC Chu, MD, FRCPC | University of Alberta, Canada |
| Tomás Reinert, MD PhD | Breast Medical Oncology Department - Oncoclinicas – Porto Alegre, Brazil |
| Daniel S. Childs, MD | Mayo Clinic, Rochester, MN, USA |
| Francesco Sabbatino, M.D., Ph.D | University of Salerno, Italy |
| Sarah Sammons, MD | Dana Farber Cancer Institute, Boston, MA, USA |
| Tahlia Scheinberg, MBBS (Hons 1) FRACP | Medical Oncology, Chris O’Brien Lifehouse, Camperdown, NSW, Australia |
| Sandor Schokker, MD PhD | Department of Radiation Oncology, Amsterdam UMC, Amsterdam, The Netherlands |
| J. Eva Selfridge, MD, PhD | University Hospitals Seidman Cancer Center, Ohio, US; Case Comprehensive Cancer Center, Ohio, US |
| Anthony Serritella, MD | Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA |
| Michael Shafique, MD | Moffitt Cancer Center-USF, Florida, USA |
| Jie Shen, PhD | University of Virginia, USA |
| Demetria Smith-Graziani, MD, MPH | Winship Cancer Institute of Emory University, USA |
| Alannah Smrke, MD | Department of Medical Oncology, BC Cancer, Vancouver, Canada |
| Tira Tan, MBBS MRCP | Division of Medical Oncology, National Cancer Centre Singapore, Singapore |
| Wei Chong Tan, MBBS (Hons) | National Cancer Centre Singapore, Singapore |
| Huarong Tang, MD | Department of Gynecological Radiotherapy, Zhejiang Cancer Hospital, Hangzhou, China |
| Jacob Thomas, MD | USC Norris Comprehensive Cancer Center, California, US |
| Consuelo Torrini, PhD | Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA |
| Silke Tribius, MD PhD | Hermann Holthusen Institute for Radiation Oncology, Asklepios Hospital St. Georg, Asklepios Tumorzentrum Hamburg, Germany |
| Erica Tsang, MD MPH FRCPC | Princess Margaret Cancer Centre, Toronto, Canada |
| Robin van Geel, PharmD, PhD | Maastricht University Medical Centre, Maastricht, Netherlands |
| David VanDerWeele, MD PhD | Hematology and Oncology, Northwestern University Feinberg School of Medicine and OncoSET Precision Oncology Program, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA |
| Dawei Wu | Clinical Trials Center, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, China |
| Li Xie, M.D, Ph.D | Shanghai Jiao Tong University School of Medicine, China |
| Eun-mi Yu, MD | Inova Health System, VA, USA |
| Irene Yu, MD | BC Cancer Surrey, Surrey, BC, Canada |
| Yongfeng Yu, MD PhD | Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China |
| Bingnan Zhang, MD | Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, TX, USA |
| Jian-Guo Zhou, MD, PhD | The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China |
| Hongcheng Zhu, MD,PhD | Fudan University Shanghai Cancer Center, Shanghai, China |
Manuscript submission guidelines can be accessed on Sage Journals.